SCHEMBL31489447

SCHEMBL31489447

CC(c1ccc(F)cc1)n1cc(-c2cnc(Cl)c(-c3ccn4nc(N)nc4c3)c2)cn1

nearest known ligand 0.37

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PIK3CG P48736 8/20 0.37
PIK3CD O00329 7/20 0.37
RIPK1 Q13546 2/20 0.37
JAK2 O60674 1/20 0.35
CREBBP Q92793 2/20 0.34
NTRK1 P04629 1/20 0.34
PAK4 O96013 1/20 0.34
JAK1 P23458 1/20 0.34
PIK3CA P42336 1/20 0.34
PIK3CB P42338 1/20 0.34
CSNK1A1 P48729 1/20 0.34
AAK1 Q2M2I8 1/20 0.34
PIP4K2C Q8TBX8 1/20 0.34
CSNK1G1 Q9HCP0 1/20 0.34
MAPK1 P28482 2/20 0.33
MET P08581 1/20 0.33
AXL P30530 1/20 0.33
GPR55 Q9Y2T6 1/20 0.33
PDPK1 O15530 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31489433 0.96 PIK3CG (0.39) PIK3CGPIK3CDRIPK1JAK2CREBBP
SCHEMBL31489875 0.91 PIK3CG (0.38) PIK3CGPIK3CDRIPK1CREBBPNTRK1
SCHEMBL31489389 0.91 RIPK1 (0.40) PIK3CGPIK3CDRIPK1CREBBPNTRK1
SCHEMBL31489277 0.91 PIK3CG (0.38) PIK3CGPIK3CDRIPK1CREBBPNTRK1
SCHEMBL31489720 0.88 PIK3CG (0.39) PIK3CGPIK3CDRIPK1JAK2PAK4
SCHEMBL31489330 0.88 PIK3CG (0.35) PIK3CGPIK3CDRIPK1JAK2NTRK1
SCHEMBL31489725 0.88 PIK3CG (0.40) PIK3CGPIK3CDRIPK1CREBBPNTRK1
SCHEMBL31489525 0.88 PIK3CG (0.40) PIK3CGPIK3CDRIPK1CREBBPNTRK1
SCHEMBL31489312 0.85 PIK3CG (0.41) PIK3CGPIK3CDRIPK1CREBBPNTRK1
SCHEMBL31489366 0.85 PIK3CG (0.49) PIK3CGPIK3CDRIPK1CREBBPPAK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025072395-A1 TRIAZOLOPYRIDINYL COMPOUNDS AS KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2025-04-03 WO disclosed